# Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

> **NCT02691923** · PHASE2 · RECRUITING · sponsor: **David W. Roberts** · enrollment: 30 (estimated)

## Conditions studied

- Brain Cancer

## Interventions

- **DRUG:** Fluorescein
- **DRUG:** Fluorescein + ALA

## Key facts

- **NCT ID:** NCT02691923
- **Lead sponsor:** David W. Roberts
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-03
- **Primary completion:** 2025-12
- **Final completion:** 2026-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-08-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02691923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02691923, "Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02691923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*